Does Rallies show Form 4 insider transactions for MASI?

Yes. Rallies tracks MASI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is MASI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MASI. It does not provide personalized investment advice.

MASI (Masimo Corporation) Stock Analysis - Insider Trades

Masimo Corporation (MASI) is a publicly traded Healthcare sector company. As of May 20, 2026, MASI trades at $178.81 with a market cap of $9.36B and a P/E ratio of -63.18. MASI moved +0.01% today. Year to date, MASI is +33.43%; over the trailing twelve months it is +14.48%. Its 52-week range spans $125.94 to $194.88. Analyst consensus is neutral with an average price target of $180.00. Rallies surfaces MASI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading MASI stock inside the company?

Recent MASI insider activity includes Sampath Anand sold 11.92K, Sampath Anand sold 6.56K, Sampath Anand sold 196, Brennan Michelle bought 100, and Brennan Michelle bought 100. Rallies tracks insider transaction dates, shares, prices, and estimated values.

MASI Key Metrics

Key financial metrics for MASI
Metric	Value
Price	$178.81
Market Cap	$9.36B
P/E Ratio	-63.18
EPS	$-2.83
Dividend Yield	1.00%
52-Week High	$194.88
52-Week Low	$125.94
Volume	703.10K
Avg Volume	0
Revenue (TTM)	$1.53B
Net Income	$-151.50M
Gross Margin	61.90%

Recent MASI Insider Trades

Sampath Anand sold 11.92K (~$1.63M) on Jan 28, 2026.
Sampath Anand sold 6.56K (~$900.16K) on Jan 28, 2026.
Sampath Anand sold 196 (~$27.07K) on Jan 28, 2026.
Brennan Michelle bought 100 (~$15.53K) on Aug 13, 2025.
Brennan Michelle bought 100 (~$15.04K) on Aug 12, 2025.

Latest MASI News

Masimo Reports <1% Bias in Newborn Pulse Oximetry, Zero Occult Events in Black, Hispanic Infants — Apr 28, 2026
Masimo’s $180 Share Sale to Danaher Faces Shareholder Fairness Probe — Apr 10, 2026
Masimo Shares Up 28.2% Past Six Months, Trades at 5.74 P/S Ratio — Mar 2, 2026
Law Firm Probes Masimo’s $180-per-Share Cash Acquisition by Danaher — Feb 25, 2026
Masimo Sees FY24 Healthcare Revenues Up 9.4%, Growth Score A Forecasts 23.9% — Feb 20, 2026

MASI Analyst Consensus

3 analysts cover MASI: 0 strong buy, 0 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $180.00.

Common questions about MASI

Who is trading MASI stock inside the company?: Recent MASI insider activity includes Sampath Anand sold 11.92K, Sampath Anand sold 6.56K, Sampath Anand sold 196, Brennan Michelle bought 100, and Brennan Michelle bought 100. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MASI?: Yes. Rallies tracks MASI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MASI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MASI. It does not provide personalized investment advice.